Scott Martin

7PUBLICATIONS

142CO-AUTHORS

Molecular targetsChemical and thermal processes in energy and combustion

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 03, 2026

Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.

|Jan 29, 2026

Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy.

Junedh M Amrute, In-Hyuk Jung, Tracy Yamawaki

|Oct 27, 2025

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Jul 08, 2025

KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077).

Kyung W Song, Christy C Ong, Eva Lin

|Oct 11, 2024

Functional RNAi Screening Identifies G2/M and Kinetochore Components as Modulators of TNFα/NF-κB Prosurvival Signaling in Head and Neck Squamous Cell Carcinoma.

Ethan L Morgan, Anthony D Saleh, Shaleeka Cornelius

|Mar 15, 2024

The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.

Junghyun Lim, Ryan Rodriguez, Katherine Williams

Pageof 2

Frequent Collaborators

Eva Lin

Nicole M Sodir

Chi-Ming Li

Marc Hafner

Katherine E Hutchinson

Tracy Yamawaki

Jeffrey T Lau

Anwesha Dey

Danilo Maddalo

Kyung W Song

Frequent Collaborators

Eva Lin

Nicole M Sodir

Chi-Ming Li

Marc Hafner